1. Section of Pharmacogenetics, Department of Physiology and Pharmacology; Karolinska Institutet; Stockholm Sweden
2. MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology; University of Liverpool; Liverpool UK
3. Department of Clinical Science, Intervention and Technology; Karolinska University Hospital Huddinge; Karolinska Institutet Stockholm Sweden
4. Cardiovascular and Metabolic Diseases Innovative Medicines, DMPK; AstraZeneca R&D; Mölndal Sweden